{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:50:27Z","timestamp":1786114227235,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,29]],"date-time":"2027-07-29T00:00:00Z","timestamp":1816819200000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.anai.2026.05.022","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:16:49Z","timestamp":1779751009000},"page":"185-193.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post\u2013COVID-19 onset of allergic conditions in a propensity-matched cohort of children and adults"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0197-7555","authenticated-orcid":false,"given":"Jessica","family":"Clarion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zella","family":"Berill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apryl","family":"Susi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cade M.","family":"Nylund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9537","key":"10.1016\/j.anai.2026.05.022_bib0001","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(06)69283-0","article-title":"Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys","volume":"368","author":"Asher","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.anai.2026.05.022_bib0002","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2023.10.025","article-title":"Impact of socioeconomic factors on allergic diseases","volume":"153","author":"Perry","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2026.05.022_bib0003","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11882-012-0295-y","article-title":"Role of viruses in the development of atopic disease in pediatric patients","volume":"12","author":"Cheung","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.anai.2026.05.022_bib0004","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jaci.2017.08.003","article-title":"Role of viral infections in the development and exacerbation of asthma in children","volume":"140","author":"Jartti","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2026.05.022_bib0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.iac.2019.03.007","article-title":"Beyond respiratory syncytial virus and rhinovirus in the pathogenesis and exacerbation of asthma: the role of Metapneumovirus, bocavirus and influenza virus","volume":"39","author":"Coverstone","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"10.1016\/j.anai.2026.05.022_bib0006","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.immuni.2023.03.014","article-title":"The ins and outs of innate and adaptive type 2 immunity","volume":"56","author":"Molofsky","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.anai.2026.05.022_bib0007","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/all.15558","article-title":"Viral infections and drug hypersensitivity","volume":"78","author":"Pichler","year":"2023","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2026.05.022_bib0008","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jaci.2004.08.009","article-title":"Cytomegalovirus infection and development of allergic diseases in early childhood: interaction with EBV infection?","volume":"114","author":"Sidorchuk","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2026.05.022_bib0009","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8421-3","article-title":"Crucial role of viral reactivation in the development of severe drug eruptions: a comprehensive review","volume":"49","author":"Shiohara","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"32","key":"10.1016\/j.anai.2026.05.022_bib0010","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.15585\/mmwr.mm6932e2","article-title":"COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020","volume":"69","author":"Godfred-Cato","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.anai.2026.05.022_bib0011","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/diseases12050095","article-title":"Long COVID in children, adults, and vulnerable populations: A comprehensive overview for an integrated approach","volume":"12","author":"Calcaterra","year":"2024","journal-title":"Diseases"},{"issue":"1","key":"10.1016\/j.anai.2026.05.022_bib0012","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/s41467-024-47176-w","article-title":"Incident allergic diseases in post-COVID-19 condition: multinational cohort studies from South Korea, Japan and the UK","volume":"15","author":"Oh","year":"2024","journal-title":"Nat Commun"},{"issue":"18","key":"10.1016\/j.anai.2026.05.022_bib0013","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.3390\/ijerph20186799","article-title":"A Single Center observational study on clinical manifestations and associated factors of pediatric long COVID","volume":"20","author":"Mancino","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.anai.2026.05.022_bib0014","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaip.2023.09.015","article-title":"Increased risk of new-onset asthma after COVID-19: A nationwide population-based cohort study","volume":"12","author":"Kim","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2026.05.022_bib0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaci.2025.07.030","article-title":"COVID-19 infection raises respiratory type 2 inflammatory disease risk, whereas vaccination is protective","volume":"157","author":"Olbrich","year":"2026","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2026.05.022_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2020-320776","article-title":"COVID-19 is not a driver of clinically significant viral wheeze and asthma","volume":"106","author":"Roland","year":"2021","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.anai.2026.05.022_bib0017","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.anai.2026.05.022_bib0018","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.3390\/v15081655","article-title":"Airway epithelial-derived immune mediators in COVID-19","volume":"15","author":"Guo","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.anai.2026.05.022_bib0019","series-title":"DXCCSR_Mapping_Program_v2022-1: CLINICAL CLASSIFICATIONS SOFTWARE REFINED (CCSR) FOR ICD-10-CM MAPPING PROGRAM","year":"2021"},{"key":"10.1016\/j.anai.2026.05.022_bib0020","series-title":"PRCCSR_Mapping_Program_v2023-1: CLINICAL CLASSIFICATIONS SOFTWARE REFINED (CCSR) FOR ICD-10-CM MAPPING PROGRAM","year":"2022"},{"key":"10.1016\/j.anai.2026.05.022_bib0021","series-title":"CCS_Services_Procedures_Mapping_Program_v2022-1: CLINICAL CLASSIFICATIONS SOFTWARE REFINED (CCSR) FOR ICD-10-CM MAPPING PROGRAM","year":"2021"},{"issue":"3","key":"10.1016\/j.anai.2026.05.022_bib0022","first-page":"119","article-title":"Uses of the AHFS classification system","volume":"20","author":"Francke","year":"1963","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.anai.2026.05.022_bib0023","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"issue":"25","key":"10.1016\/j.anai.2026.05.022_bib0024","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.anai.2026.05.022_bib0025","series-title":"Analysis of Observational Health Care Data Using SAS","author":"Faries","year":"2010"},{"issue":"8","key":"10.1016\/j.anai.2026.05.022_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.anai.2026.05.022_bib0027","unstructured":"Saul B. smd: compute Standardized Mean Differences. version 0.7.0. CRAN. Accessed December 9, 2025. Available at: https:\/\/CRAN.R-project.org\/package=smd"},{"key":"10.1016\/j.anai.2026.05.022_bib0028","unstructured":"R Core Team. R: A language and environment for statistical computing. version 4.4.1. R Foundation for Statistical Computing. Accessed March 3, 2025. Available at: https:\/\/www.R-project.org\/."},{"issue":"3","key":"10.1016\/j.anai.2026.05.022_bib0029","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41591-020-01227-z","article-title":"NHLBI LungMap consortium; human cell atlas lung biological network. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics","volume":"27","author":"Muus","year":"2021","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.022_bib0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.anai.2026.05.022_bib0031","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/cea.14131","article-title":"Burden of allergic disease among ethnic minority groups in high-income countries","volume":"52","author":"Jones","year":"2022","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.anai.2026.05.022_bib0032","first-page":"60","article-title":"Emerging health disparities during the COVID-19 pandemic","volume":"13","author":"Mheidly","year":"2022","journal-title":"Avicenna J Med"},{"issue":"2","key":"10.1016\/j.anai.2026.05.022_bib0033","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.acap.2022.07.018","article-title":"Well-child care disparities in U.S. military health system","volume":"23","author":"Hammon","year":"2023","journal-title":"Acad Pediatr"},{"issue":"7","key":"10.1016\/j.anai.2026.05.022_bib0034","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/CORR.0000000000000994","article-title":"Does universal insurance and access to care influence disparities in outcomes for pediatric patients with osteomyelitis?","volume":"478","author":"Young","year":"2020","journal-title":"Clin Orthop Relat Res"},{"issue":"8","key":"10.1016\/j.anai.2026.05.022_bib0035","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpediatrics.2010.100","article-title":"Differences in prevalence, treatment, and outcomes of asthma among a diverse population of children with equal access to care: findings from a study in the military health system","volume":"164","author":"Stewart","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"7","key":"10.1016\/j.anai.2026.05.022_bib0036","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.22080","article-title":"Military inhalational exposures outside the theater of conflict and chronic respiratory symptoms","volume":"8","author":"Hosseini","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.anai.2026.05.022_bib0037","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41390-022-02111-x","article-title":"Post-COVID-19 conditions in children and adolescents diagnosed with COVID-19","volume":"95","author":"Kostev","year":"2024","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1016\/j.anai.2026.05.022_bib0038","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-064615","article-title":"COVID-19 and asthma onset in children","volume":"153","author":"Senter","year":"2024","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.anai.2026.05.022_bib0039","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11882-020-00986-6","article-title":"Cutaneous manifestations related to COVID-19 immune dysregulation in the pediatric age group","volume":"21","author":"Larenas-Linnemann","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.anai.2026.05.022_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ASW.0000000000000118","article-title":"Clinical Features and Outcomes of Acute versus Chronic urticaria Triggered by COVID-19 Infection","volume":"37","author":"Oztas Kara","year":"2024","journal-title":"Adv Skin Wound Care"},{"issue":"2","key":"10.1016\/j.anai.2026.05.022_bib0041","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/all.14452","article-title":"Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status","volume":"76","author":"Du","year":"2021","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.anai.2026.05.022_bib0042","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1016\/j.jaip.2023.08.038","article-title":"COVID-19 and its impact on common diseases in the allergy clinics","volume":"11","author":"Kocat\u00fcrk","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2026.05.022_bib0043","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-060531","article-title":"Patterns in the development of pediatric allergy","volume":"152","author":"Gabryszewski","year":"2023","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.anai.2026.05.022_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106597","article-title":"Post-COVID-19 multimorbidity incidence by previous vaccination status in people with a preexisting comorbidity: a population-based cohort study","volume":"91","author":"Liu","year":"2025","journal-title":"J Infect"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626002279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120626002279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T20:33:26Z","timestamp":1785962006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120626002279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1081120626002279"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2026.05.022","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post\u2013COVID-19 onset of allergic conditions in a propensity-matched cohort of children and adults","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2026.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American College of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}